Baudax Bio logo
Baudax Bio BXRX

Quartalsbericht 2023-Q3
hinzugefügt 20.11.2023

report update icon

Baudax Bio DSO 2011-2026 | BXRX

DSO Jährlich Baudax Bio

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
126 100 37.8 - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
126 37.8 88

DSO Vierteljährlich Baudax Bio

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - 178 186 124 - 104 86.7 49.3 - 68.4 13.3 28.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
186 13.3 93.2

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
115 $ 20.29 -1.98 % $ 2.56 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
20.6 $ 0.8 -5.3 % $ 4.36 M chinaChina
Axsome Therapeutics Axsome Therapeutics
AXSM
105 $ 166.0 -0.23 % $ 8.26 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 3.74 -2.23 % $ 1.12 B canadaCanada
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Certara Certara
CERT
89.6 $ 7.22 2.34 % $ 1.16 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
59.5 $ 23.78 -0.42 % $ 2.91 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
30.4 $ 17.9 -1.38 % $ 459 M usaUSA
Exelixis Exelixis
EXEL
43.4 $ 40.5 -1.29 % $ 11 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
31.9 $ 26.3 -2.08 % $ 704 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Codexis Codexis
CDXS
32.9 $ 1.02 -0.33 % $ 74.9 M usaUSA
Galapagos NV Galapagos NV
GLPG
56.5 $ 33.13 -2.82 % $ 2.69 B belgiumBelgium
Genmab A/S Genmab A/S
GMAB
97.9 $ 27.66 -6.71 % $ 17.7 B danmarkDanmark
Halozyme Therapeutics Halozyme Therapeutics
HALO
93.4 $ 68.58 -1.82 % $ 8.22 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
78.4 - -10.17 % $ 12.2 K usaUSA
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
37.8 $ 28.32 -2.01 % $ 1.63 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
41 $ 6.3 -3.67 % $ 51.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Agenus Agenus
AGEN
4.13 $ 3.27 -2.1 % $ 1.17 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
47.4 $ 28.57 -2.16 % $ 1.66 B usaUSA
Immuron Limited Immuron Limited
IMRN
148 $ 0.75 -0.69 % $ 6.46 M australiaAustralia
Inhibrx Inhibrx
INBX
31.1 $ 76.39 -1.42 % $ 3.6 B usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
3.83 $ 0.8 -2.44 % $ 1.96 M canadaCanada